A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH Trademark

Trademark Overview


On Friday, July 2, 2021, a trademark application was filed for A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH with the United States Patent and Trademark Office. The USPTO has given the A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH trademark a serial number of 90809062. The federal status of this trademark filing is REGISTERED as of Tuesday, July 12, 2022. This trademark is owned by ELIM Holdings, LLC. The A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; Medical research services; Medical research services in the field of cancer; Medical and scientific research in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and T cell receptors; Research and development in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and T cell receptors.; Scientific research for medical purposes in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and T cell receptors
a translational approach to preclinical research

General Information


Serial Number90809062
Word MarkA TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH
Filing DateFriday, July 2, 2021
Status700 - REGISTERED
Status DateTuesday, July 12, 2022
Registration Number6791631
Registration DateTuesday, July 12, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical research; Medical research services; Medical research services in the field of cancer; Medical and scientific research in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and T cell receptors; Research and development in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and T cell receptors.; Scientific research for medical purposes in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and T cell receptors

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 14, 2021
Primary Code042
First Use Anywhere DateThursday, August 8, 1996
First Use In Commerce DateThursday, August 8, 1996

Trademark Owner History


Party NameELIM Holdings, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Party NameELIM Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Trademark Events


Event DateEvent Description
Friday, September 15, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 12, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 12, 2022REGISTERED-SUPPLEMENTAL REGISTER
Monday, June 6, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 2, 2022ASSIGNED TO LIE
Friday, May 27, 2022ASSIGNED TO LIE
Friday, May 20, 2022APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, May 18, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, May 18, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 18, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, May 18, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 19, 2021NON-FINAL ACTION E-MAILED
Friday, November 19, 2021NON-FINAL ACTION WRITTEN
Tuesday, November 2, 2021ASSIGNED TO EXAMINER
Tuesday, September 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 6, 2021NEW APPLICATION ENTERED